Proactive Investors - Run By Investors For Investors

Chemistree Technology names Sheldon Aberman its first chief cannabis officer

Aberman has been at the cannabis-centric investment company since its founding, and he joined its board in October 2018
Chemistree Logo
Aberman also serves as a consultant for Cannabis Grow and oversees Cannabis Consulting Co

Chemistree Technology Inc (CSE:CHM) (OTCMKTS: CHMJF) tapped Sheldon Aberman as its first ever CCO. But at this Vancouver company, the second ‘C’ stands for cannabis, as in chief cannabis officer.

Aberman has been at the cannabis-centric investment company since its founding, and he joined its board in October 2018. He is considered an expert in cultivation with 17 years of experience in the industry. Currently he also serves as a consultant for Cannabis Grow and oversees Cannabis Consulting Co.

The stock grew 1.7% to $0.60 on the CSE and 1.1% to US$0.45 on OTC markets.

READ: Chemistree Technology adds cannabis exec Nicholas Zitelli to board

“Sheldon is a world-renowned leader in the cannabis sector,” President Karl Kottmeier said. “He has tremendous experience and an unrivalled contact list across the international cannabis community. With this appointment we are even better positioned to continue to build and optimize existing business and expand our operations across the United States and ultimately to international markets.”

Before Chemistree dubbed him its chief cannabis officer, Aberman designed the first licensed cultivation and processing facility in Michigan in 2016 with Cannabis Consulting. Before that, he managed Canadian Cannabis Corporation’s 312,000 square-foot cultivation center outside Toronto.

His journey began at Gotta Grow Wholesale, a plant nutrient seller, as a sales rep in 2003, where he went on to become director of US sales and increased revenue 800%.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CHM profile View Profile

Chemistree Technology Inc. Timeline

Related Articles

cannabis flower
Mon
The company's footprint continues to grow as it focuses on becoming a globally recognized house of brands with a broad portfolio of clients across North America
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 30 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
cannabis extraction
April 09 2019
NextLeaf Solutions is developing intellectual property around converting the cannabis plant into infused products through a scalable, repeatable process
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use